Small molecule targeting of the actin associating protein tropomyosin Tpm3.1 increases neuroblastoma cell response to inhibition of Rac‐mediated multicellular invasion

The migration and invasion of cells through tissues in the body is facilitated by a dynamic actin cytoskeleton. The actin‐associating protein, tropomyosin Tpm3.1 has emerged to play important roles in cell migration and invasion. To date, investigations have focused on single cell migration and inva...

Full description

Saved in:
Bibliographic Details
Published inCytoskeleton (Hoboken, N.J.) Vol. 75; no. 7; pp. 307 - 317
Main Authors Mitchell, Camilla B., Stehn, Justine R., O'Neill, Geraldine M.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The migration and invasion of cells through tissues in the body is facilitated by a dynamic actin cytoskeleton. The actin‐associating protein, tropomyosin Tpm3.1 has emerged to play important roles in cell migration and invasion. To date, investigations have focused on single cell migration and invasion where Tpm3.1 expression is inversely associated with Rac GTPase‐mediated cell invasion. While single cell and collective cell invasion have many features in common, collective invasion is additionally impacted by cell–cell adhesion, and the role of Tpm3.1 in collective invasion has not been established. In the present study we have modelled multicellular invasion using neuroblastoma spheroids embedded in 3D collagen and analysed the function of Tpm3.1 using recently established compounds that target the Tpm3.1 C‐terminus. The major findings from our study reveal that combined Rac inhibition and Tpm3.1 targeting result in greater inhibition of multicellular invasion than either treatment alone. Together, the data suggest that Tpm3.1 disruption sensitises neuroblastoma cells to inhibition of Rac‐mediated multicellular invasion.
Bibliography:Funding information
This work was generously supported by a Childhood Cancer Cytoskeleton Consortium (C4) Fellowship from The Kids’ Cancer Project to C.M.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1949-3584
1949-3592
DOI:10.1002/cm.21452